Switch to:

Theravance Biopharma EV-to-Revenue

: 15.73 (As of Today)
View and export this data going back to 2014. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Theravance Biopharma's enterprise value is $1,208.03 Mil. Theravance Biopharma's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was $76.80 Mil. Therefore, Theravance Biopharma's EV-to-Revenue for today is 15.73.

NAS:TBPH' s EV-to-Revenue Range Over the Past 10 Years
Min: 5.3   Med: 23.55   Max: 180.5
Current: 15.74

5.3
180.5

During the past 8 years, the highest EV-to-Revenue of Theravance Biopharma was 180.50. The lowest was 5.30. And the median was 23.55.

NAS:TBPH's EV-to-Revenue is ranked higher than
53% of the 862 Companies
in the Biotechnology industry.

( Industry Median: 18.48 vs. NAS:TBPH: 15.74 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2020-09-28), Theravance Biopharma's stock price is $15.56. Theravance Biopharma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $1.32. Therefore, Theravance Biopharma's PS Ratio for today is 11.78.


Theravance Biopharma EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Theravance Biopharma Annual Data
Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only 10.68 28.90 90.46 22.76 23.24

Theravance Biopharma Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.33 21.76 23.24 17.54 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Theravance Biopharma EV-to-Revenue Distribution

* The bar in red indicates where Theravance Biopharma's EV-to-Revenue falls into.



Theravance Biopharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Theravance Biopharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1208.025/76.796
=15.73

Theravance Biopharma's current Enterprise Value is $1,208.03 Mil.
Theravance Biopharma's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was 12.427 (Sep. 2019 ) + 29.499 (Dec. 2019 ) + 19.862 (Mar. 2020 ) + 15.008 (Jun. 2020 ) = $76.80 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Theravance Biopharma  (NAS:TBPH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Theravance Biopharma's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=15.56/1.321
=11.78

Theravance Biopharma's share price for today is $15.56.
Theravance Biopharma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was 0.222 (Sep. 2019 ) + 0.526 (Dec. 2019 ) + 0.334 (Mar. 2020 ) + 0.239 (Jun. 2020 ) = $1.32.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Theravance Biopharma EV-to-Revenue Related Terms


Theravance Biopharma EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)